Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

RDEA119 and Sorafenib Combination Dose Escalation Study

This study has been completed.
Information provided by (Responsible Party):
Bayer Identifier:
First received: November 4, 2008
Last updated: October 14, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2012
  Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: September 24, 2015